| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/05/2012 | US20120083590 Polypeptides having dna polymerase activity |
| 04/05/2012 | US20120083589 Antibody Modulating The Differentiation And Function Of Dendritic Cells Via Binding Intercellular Adhesion Molecule-1 And Use Thereof |
| 04/05/2012 | US20120083588 Neutral amino acid transporter and gene thereof |
| 04/05/2012 | US20120083587 Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (ma) |
| 04/05/2012 | US20120083004 Diagnostic Method for Celiac Sprue |
| 04/05/2012 | US20120082715 Stabilized products, processes and devices for preparing the same |
| 04/05/2012 | US20120082693 Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strain |
| 04/05/2012 | US20120082686 Neovascular-Targeted Immunoconjugates |
| 04/05/2012 | US20120082684 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene |
| 04/05/2012 | US20120082682 Il-13 binding protein |
| 04/05/2012 | US20120082681 Anti-il12rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders |
| 04/05/2012 | US20120082680 Antagonists of pcsk9 |
| 04/05/2012 | US20120082679 Antagonists of pcsk9 |
| 04/05/2012 | US20120082676 Methods for preventing and treating angioedema |
| 04/05/2012 | US20120082674 Enterococcus antigens |
| 04/05/2012 | US20120082673 Human cytokine receptor |
| 04/05/2012 | US20120082670 Cd33 binding agents |
| 04/05/2012 | US20120082667 Antibodies That Specifically Bind To A Beta Oligomers And Use Thereof |
| 04/05/2012 | US20120082666 Antibody compositions and methods of use |
| 04/05/2012 | US20120082664 Optimized antibodies that target cd19 |
| 04/05/2012 | US20120082663 Anti-cmet antagonists |
| 04/05/2012 | US20120082662 Anti-cmet antagonists |
| 04/05/2012 | US20120082661 Anti-bcma antibodies |
| 04/05/2012 | US20120082622 Macaca fascicularis CCL17 |
| 04/05/2012 | US20120082618 Prostate cancer diagnosis and treatment |
| 04/05/2012 | CA2849982A1 Antibody specifically binding synovial microvasculature of arthritis patients |
| 04/05/2012 | CA2813203A1 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier |
| 04/05/2012 | CA2813133A1 Anti-ceacam6 antibodies and uses thereof |
| 04/05/2012 | CA2813098A1 Means and methods for diagnosing cancer using an antibody which specifically binds to braf v600e |
| 04/05/2012 | CA2812957A1 Polypeptides that bind to human complement component c5 |
| 04/05/2012 | CA2812756A1 Antibody against human prostaglandin e2 receptor ep4 |
| 04/05/2012 | CA2812644A1 Compositions and methods for treating neoplasia |
| 04/05/2012 | CA2812631A1 Anti-cd38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and nhl |
| 04/05/2012 | CA2812430A1 Humanized anti-tnf-.alpha. antibody and antigen-binding fragment (fab) thereof and use of the same |
| 04/05/2012 | CA2805361A1 Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis |
| 04/04/2012 | EP2436774A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 04/04/2012 | EP2436697A1 Chimeric and humanised monoclonal antibodies against interleukin-13 |
| 04/04/2012 | EP2436696A1 Method of providing disease-specific binding molecules and targets |
| 04/04/2012 | EP2436695A1 Methods for treating and preventing fibrosis by IL-21 / IL-21R antagonists |
| 04/04/2012 | EP2436397A1 Pharmaceutical composition containing antagonist of egf family ligand as component |
| 04/04/2012 | EP2435568A1 A collection and methods for its use |
| 04/04/2012 | EP2435567A1 Cdc45l peptides and vaccines including the same |
| 04/04/2012 | EP2435482A2 Antigen-binding proteins |
| 04/04/2012 | EP2435481A1 Il-13 binding protein |
| 04/04/2012 | EP2435480A1 Biparatopic protein constructs directed against il-23 |
| 04/04/2012 | EP2435479A1 Antigen-binding proteins |
| 04/04/2012 | EP2435478A1 Antigen-binding proteins |
| 04/04/2012 | EP2435477A1 Antigen-binding proteins |
| 04/04/2012 | EP2435476A2 Avian derived antibodies |
| 04/04/2012 | EP2435475A1 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| 04/04/2012 | EP2435474A2 A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| 04/04/2012 | EP2435473A1 Tri- or tetraspecific antibodies |
| 04/04/2012 | EP2435079A2 Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease |
| 04/04/2012 | EP2435078A1 Methods of treating inflammation |
| 04/04/2012 | EP2435077A1 Stim2-mediated capacitive calcium entry |
| 04/04/2012 | EP2435075A2 Antigen-binding proteins |
| 04/04/2012 | EP2435073A1 CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF |
| 04/04/2012 | EP2435067A2 Stem cell targeting |
| 04/04/2012 | EP1694706B1 Modified anti-cd52 antibody |
| 04/04/2012 | EP1677820B1 Colorectal cancer antigen |
| 04/04/2012 | EP1660513B9 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 04/04/2012 | EP1397158B1 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS |
| 04/04/2012 | EP0783893B1 Inhibition of abnormal growth of synovial cells using il-6 antagonist as active ingredient |
| 04/04/2012 | CN102405238A 测定癌症组织学类型的抗体鸡尾酒、测定试剂盒及测定方法 Determination of cancer histologic type of antibody cocktail assay kit and determination |
| 04/04/2012 | CN102405237A 利用EphA3抗体治疗白血病和慢性骨髓增生性疾病 Antibody therapy using EphA3 leukemia and chronic myeloproliferative disorders |
| 04/04/2012 | CN102405236A 改进的抗-tnfr1多肽，抗体可变结构域和拮抗剂 Improved anti -tnfr1 polypeptide, antibody variable domains and antagonists |
| 04/04/2012 | CN102405235A Specific binding proteins and uses thereof |
| 04/04/2012 | CN102405234A 用于天疱疮的含有抗Fas配体抗体的药物 For containing an anti-Fas ligand antibody drug pemphigus |
| 04/04/2012 | CN102405233A Improved anti-serum albumin binding variants |
| 04/04/2012 | CN102405232A Improved anti-serum albumin binding variants |
| 04/04/2012 | CN102405231A Optimized fc variants |
| 04/04/2012 | CN102405230A Antibody fusion proteins with modified fcrn binding sites |
| 04/04/2012 | CN102405228A 纯化血浆蛋白的手段和其实现方法 Means the purification of plasma proteins, and its implementation method |
| 04/04/2012 | CN102399753A 一种小麦矮腥黑粉菌的特异性单克隆抗体及免疫荧光检测方法 Specific monoclonal antibodies and immunofluorescence method dwarf wheat fungus Tilletia |
| 04/04/2012 | CN102399752A 心脏型脂肪酸结合蛋白单克隆抗体mcf1及其应用 Heart-type fatty acid binding protein and its application of monoclonal antibodies mcf1 |
| 04/04/2012 | CN102399751A Anti-mycobacterium tuberculosis monoclonal antibody, epitope recognized by anti-mycobacterium tuberculosis monoclonal antibody, and use thereof |
| 04/04/2012 | CN102399750A 重组msg1蛋白单克隆抗体及检测猪嗜血支原体特异性抗体的阻断elisa方法 Monoclonal antibodies and recombinant proteins msg1 bloodthirsty swine mycoplasma detection of specific antibodies to block elisa method |
| 04/04/2012 | CN102399289A 一种人源抗人IgE的抗体Fab片段、编码基因及用途 A humanized anti-human IgE antibody Fab fragments encoding gene and uses |
| 04/04/2012 | CN102399288A 针对免疫球蛋白Fc段的单域重链抗体 For single domain heavy chain antibody immunoglobulin Fc segment |
| 04/04/2012 | CN102399287A 大菱鲆免疫球蛋白单克隆抗体的制备方法 Preparation turbot immunoglobulin monoclonal antibodies |
| 04/04/2012 | CN102399266A 一种人源性电压门控钾通道1.5免疫原性肽段及其用途 A human-derived voltage-gated potassium channel 1.5 immunogenic peptides and their uses |
| 04/04/2012 | CN101437537B 癌症疫苗 Cancer Vaccine |
| 04/04/2012 | CN101307108B 抗磷酸化Tau蛋白抗体及其在AD症异常磷酸化Tau蛋白水平测定上的用途 Anti-phosphorylated Tau protein antibodies and abnormal phosphorylation of Tau protein in AD disease levels were measured on the use of |
| 04/03/2012 | US8148499 Vaccine |
| 04/03/2012 | US8148497 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/03/2012 | US8148496 Multivalent antibody constructs |
| 04/03/2012 | US8148493 Method for inhibiting “melanoma inhibitory activity” MIA |
| 04/03/2012 | US8148346 Compositions and methods for the systemic treatment of arthritis |
| 04/03/2012 | US8148343 Tumor suppressor factor |
| 04/03/2012 | US8148327 Aldosterone induced elastin production |
| 04/03/2012 | US8148154 Method for preparation of single chain antibodies |
| 04/03/2012 | US8148143 Method and composition for genetically modifying non-human cells and animals |
| 04/03/2012 | US8148126 Polymerase |
| 04/03/2012 | US8148125 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 04/03/2012 | US8148109 Interferon-like proteins and uses thereof |
| 04/03/2012 | US8148093 Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
| 04/03/2012 | US8148080 Gene and protein relating to hepatocellular carcinoma and methods of use thereof |
| 04/03/2012 | US8147840 Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid |
| 04/03/2012 | US8147835 Molecularly engineered binding domain-immunoglobulin fusion proteins, including single chain Fv-immunoglobulin fusion protein useful for treating malignant conditions and B-cell disorders, such as disease caused by autoantibody production; chronic lymphocytic leukemia |
| 04/03/2012 | US8147834 Anti-TGF-beta receptor II antibodies |